{"id":196591,"name":"INDEPENDENT PHARMACY COOPERATIVE","slug":"independent-pharmacy-cooperative","state":"WI","description":"Largest group purchasing organization for independent pharmacies.","totalSpending":1180000,"filings":23,"yearlySpending":[{"year":2018,"income":180000},{"year":2019,"income":240000},{"year":2020,"income":120000},{"year":2021,"income":180000},{"year":2022,"income":240000},{"year":2024,"income":100000},{"year":2025,"income":120000}],"firms":["FORBES-TATE"],"lobbyists":["JERRY DRISCOLL","JEFFREY FORBES","JEFFREY STRUNK","ELIZABETH GREER","DERRICK WHITE","JEFFREY SADOSKY","FRANKLYN STEINBERG","CYNTHIA BROWN","KRISTINA DUNKLIN","MICHAEL WILLIAMS","PAUL DIOGUARDI"],"issues":["HCR","PHA","MMM","BUD"],"sampleDescriptions":["Issues related to Pharmacy Regulation; Issues related to the MAC Transparency Act; Issues related to opioid addiction; Issues related to drug pricing.","Issues related to Pharmacy Regulation; Issues related to the MAC Transparency Act; Issues related to opioid addiction;Issues related to drug pricing.Issues related to Pharmacy Benefit Manager transparency.","Issues related to Pharmacy Regulation; Issues related to the MAC Transparency Act; Issues related to opioid addiction; Issues related to drug pricing; Issues related to Pharmacy Benefit Manager transparency.","Issues related to pharmacy regulation, the MAC Transparency Act, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency.","Issues related to direct and indirect remuneration (DIR) fees.","Issues related to H.R. 925 - The Heroes Act.","Issues related to pharmacy regulation, the MAC Transparency Act, Provider Status, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency.","Issues related to direct and indirect remuneration (DIR) fees; Issues related to provider status and Medicare reimbursement.","Issues related to pharmacy regulation, Provider Status, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency; Issues related to S. 127 - Pharmacy Benefit Manager Transparency Act of 2023; Issues related to S. 1339 - Pharmacy Benefit Manager Reform Act; Issues related to H.R. 3561 - PATIENT Act of 2023; Issues related to S. 2973 - Modernizing and Ensuring PBM Accountability Act; Issues related to H.R. 5378 - the Lower Costs, More Transparency Act.","Issues related to pharmacy regulation, Provider Status, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency and reform; Issues related to S.127 - Pharmacy Benefit Manager Transparency Act of 2023; Issues related to S.1339 - Pharmacy Benefit Manager Reform Act; Issues related to H.R.3561 - PATIENT Act of 2023; Issues related to S.2973 - Modernizing and Ensuring PBM Accountability Act; Issues related to H.R.5378 - the Lower Costs, More Transparency Act.","Issues related to pharmacy regulation, Provider Status, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency and reform; Issues related to S. 127 - Pharmacy Benefit Manager Transparency Act of 2023; Issues related to S. 1339 - Pharmacy Benefit Manager Reform Act; Issues related to H.R. 3561 - PATIENT Act of 2023; Issues related to S. 2973 - Modernizing and Ensuring PBM Accountability Act; Issues related to H.R. 5378 - the Lower Costs, More Transparency Act.","Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act.","Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation Program in H.R. 1 - the One Big Beautiful Bill Act.","Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2477 - Equitable Community Access to Pharmacist Services Act.","Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation Program in the One Big Beautiful Bill Act (P.L. 119-21)."],"years":[2018,2019,2020,2021,2022,2024,2025]}